John Berman
Vice President of Finance & AdministrationMr. John Berman has been Vice President of Finance of Larimar Therapeutics, Inc. (formerly known as Chondrial Therapeutics, Inc.). since January 2017and has been its Vice President of Administration since August 2023 and had been its Vice President of Operations since January 2017 until August 2023. He serves as the Vice President of Finance and Operations & Treasurer for Chondrial Therapeutics Holdings, LLC. Mr. Berman experience at Teva Pharmaceutical Industries where he held various positions of increasing responsibility. Most recently, Mr. Berman held the position of Senior Director of Corporate Alliance Management, where he worked closely for some of the largest brands in the Teva portfolio on both R&D and commercial alliances. Prior to that, he worked on the commercial side of the business where he led the finance team for the branded US Oncology Business. Mr. Berman also served in Teva’s R&D organization where he managed finance and business operations. Prior to joining Teva, John worked in financial planning and analysis at Cell Pathways, CDNow, Toll Brothers, and PricewaterhouseCoopers. Mr. Berman earned a B.A. in Economics from the College of Arts and Sciences at the University of Pennsylvania, and an MBA from the Wharton School at the University of Pennsylvania. Mr. Berman is a Certified Public Accountant and holds the Chartered Financial Analyst designation.
Positions
- Company NameLarimar Therapeutics, Inc.Stock CodeLRMRPositionVice President of Finance & AdministrationColleagues
- CSCarole S. Ben-MaimonCEO & Director
- JTJoseph TruittIndependent Chairman of the Board
- MCMichael CelanoSecretary & CFO
- GSGopi ShankarChief Development Officer
- JBJohn B. HarlowPresident & COO
- JSJonathan S. LeffIndependent Director
- FEFrank Edward ThomasIndependent Director
- TEThomas Edward HamiltonIndependent Director
